Hexarelin Research Hub — GH Secretagogue & Cardiac Studies
Hexarelin is a synthetic GH-releasing hexapeptide widely cited in growth-hormone secretagogue and cardiac research models. This hub aggregates Ares Research's reference material on Hexarelin mechanism, dosing literature, and head-to-head comparisons with other GHRPs.
What this hub covers
- GHS-R1a agonism and downstream GH/cortisol kinetics
- Cardioprotective literature and CD36 binding
- Comparisons to GHRP-2, GHRP-6, and ipamorelin
- Tachyphylaxis and dose-frequency research
- Reconstitution and storage
Hexarelin research articles
All research →Hexarelin Benefits and Side Effects: A Research Guide
Published benefits, side effects, and class comparisons for Hexarelin — the high-potency GHRP with dual pituitary GHS-R1a and cardiac CD36 activity that defines its place in growth-hormone secretagogue research.
Read article →GHRP-2 Benefits and Side Effects: A Research Guide
Published benefits, side effects, and class comparisons for GHRP-2 (pralmorelin) — the clinically validated GH-secretagogue used in diagnostic pituitary-reserve testing and GHRP-class research.
Read article →Ipamorelin Benefits and Side Effects: A Research Guide
Published benefits, side effects, and GHRP comparisons for ipamorelin — the most receptor-selective GHRP and standard partner for GHRH analogues.
Read article →Related research hubs
Researchers studying Hexarelin commonly cross-reference these compounds.
CJC-1295 is a tetrasubstituted GHRH(1-29) analog studied in two forms: with a drug-affinity complex (DAC) that binds serum albumin and extends half-life to days, and without DAC (also called Mod GRF 1-29) for short, pulsatile GH stimulation.
Explore hub →Ipamorelin is a pentapeptide growth hormone secretagogue and selective agonist of the ghrelin (GHS-R1a) receptor. It is the most receptor-selective GHRP in the published research, notable for stimulating GH release without significantly elevating cortisol, prolactin or aldosterone.
Explore hub →Recombinant human growth hormone (somatropin) is one of the most extensively studied endocrine compounds in the published literature. This hub aggregates Ares Research's HGH reference material — receptor signalling, dose-response, body composition, longevity, and head-to-head comparisons with peptide GH-axis modulators.
Explore hub →Hexarelin research FAQ
- What is Hexarelin?
- Hexarelin is a synthetic hexapeptide GH-releasing peptide (GHRP) that activates the GHS-R1a receptor and is widely cited in growth-hormone secretagogue and cardiac research models.
- How does Hexarelin compare to GHRP-2 and Ipamorelin?
- Hexarelin produces the largest acute GH spike but with more pronounced cortisol/prolactin elevations and faster tachyphylaxis than ipamorelin, which is the most receptor-selective GHRP in the literature.
- How is Hexarelin stored?
- Lyophilized Hexarelin is stable at 2–8 °C protected from light. After reconstitution, refrigerate and use within the COA's documented window.
All content on this hub is provided strictly for laboratory research purposes. Compounds listed are not for human or veterinary consumption. See our research-use disclosure for full terms.